Suchergebnisse - "Strub-Wourgaft, Nathalie"

PubPharm (7)

1

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense : a multicentre, open-label, single-arm, phase 2/3 trial

enthalten in: The Lancet. Infectious diseases | 2023

von Betu Kumeso, V. | Kalonji, W. | Rembry, S. | +28

CommentIn: Lancet Infect Dis. 2023 Apr;23(4):387-388. - PMID 36460028

2

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Torrico, F. | Gascón, J. | Ortiz, L. | +11

3

Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis : a multicentre, single-arm, open-label, phase 2-3 trial

enthalten in: The Lancet. Global health | 2022

von Kande Betu Kumesu, V. | Mutombo Kalonji, W. | Bardonneau, C. | +20

4

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA) : a phase 2, double-blind, randomised trial

enthalten in: The Lancet. Infectious diseases | 2021

von Torrico, F. | Gascón, J. | Barreira, F. | +34

CommentIn: Lancet Infect Dis. 2021 Aug;21(8):1057-1058. - PMID 33836159

5

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens : a proof-of-concept, randomised, placebo-controlled trial

enthalten in: The Lancet. Infectious diseases | 2018

von Torrico, F. | Gascon, J. | Ortiz, L. | +52

CommentIn: Lancet Infect Dis. 2018 Apr;18(4):363-365. - PMID 29352705

6

Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis : a pivotal multicentre, randomised, non-inferiority trial

enthalten in: Lancet (London, England) | 2018

von Mesu, V. | Kalonji, W. | Bardonneau, C. | +23

ErratumIn: Lancet. 2018 Jan 13;391(10116):124. - PMID 29129438

7

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis : Phase II Randomized Trial

enthalten in: PLoS neglected tropical diseases | 2016

von Wasunna, M. | Njenga, S. | Balasegaram, M. | +20

1
[1]